Vulnerability in Linecorp Line
CVE-2023-38848
An issue in rmc R Beauty CLINIC Line v.13.6.1 allows a remote attacker to obtain sensitive information via crafted GET request.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.
EPSS exploit prediction
EPSS: 0.007 (51.1th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 51st percentile — 51.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.007 · newest: 0.007 · change: 0.000
Affected products
- Linecorp Line — versions 13.6.1
Weakness classification (CWE)
References
- liff.line.me/1657640647-Wk2xYj38 (Product)
- github.com/syz913/CVE-reports/blob/main/CVE-2023-38848.md (Exploit, Third Party Advisory)
Frequently asked questions
- What is CVE-2023-38848?
- CVE-2023-38848 is a high-severity vulnerability in Linecorp Line, classified under Improper Access Control. CVSS score: 7.5/10. Published 2023-10-25.
- How severe is CVE-2023-38848?
- High severity. CVSS v3 base score is 7.5 out of 10.